NEW YORK (GenomeWeb News) – The Centre for Commercialization of Regenerative Medicine and Nikon has reached a deal aimed at high-throughput studies of how stem cells respond to test molecules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.